Nevertheless, tumor-derived lactate has been found to enhance the expression of PD1 on a subset of ILCs that are T-bet+NK1.1− within the tumor microenvironment (Figure 1), which led to diminished signaling of mammalian target of rapamycin (mTOR) together with elevated uptake of fatty acids. The gene discussed is MTOR; the disease is neoplasm.